Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-05-30
DOI
10.1038/s41591-023-02380-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression
- (2023) Xue-Ning Shen et al. CLINICAL CHEMISTRY
- Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer’s Disease
- (2023) Pratishtha Chatterjee et al. JOURNAL OF ALZHEIMERS DISEASE
- Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model
- (2022) Carolyn N. Mann et al. Science Translational Medicine
- Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years
- (2022) Keith A. Josephs et al. NEUROLOGY
- Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
- (2022) Amaryllis A. Tsiknia et al. MOLECULAR PSYCHIATRY
- Menopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women
- (2022) Rebecca C Thurston et al. NEUROLOGY
- Plasma biomarker profiles in autosomal dominant Alzheimer’s disease
- (2022) Charlotte Johansson et al. BRAIN
- Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
- (2022) Rik Ossenkoppele et al. NATURE MEDICINE
- Lecanemab in Early Alzheimer’s Disease
- (2022) Christopher H. van Dyck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex
- (2021) Peng Wang et al. Nature Communications
- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Reactive astrocyte nomenclature, definitions, and future directions
- (2021) Carole Escartin et al. NATURE NEUROSCIENCE
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
- (2021) Joana B Pereira et al. BRAIN
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults
- (2021) Priya Palta et al. NEUROBIOLOGY OF AGING
- Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
- (2021) Rik Ossenkoppele et al. JAMA Neurology
- Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease
- (2021) Amit Kumar et al. JOURNAL OF NEUROCHEMISTRY
- Connectomics in Brain Aging and Dementia – The Background and Design of a Study of a Connectome Related to Human Disease
- (2021) Ann D. Cohen et al. Frontiers in Aging Neuroscience
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
- (2021) Andréa L. Benedet et al. JAMA Neurology
- Meta-analysis of human prefrontal cortex reveals activation of GFAP and decline of synaptic transmission in the aging brain
- (2020) Wasco Wruck et al. Acta Neuropathologica Communications
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- 18F-MK-6240 PET for early and late detection of neurofibrillary tangles
- (2020) Tharick A Pascoal et al. BRAIN
- Determining Amyloid-β positivity using [18F]AZD4694 PET imaging
- (2020) Joseph Therriault et al. JOURNAL OF NUCLEAR MEDICINE
- Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults
- (2019) Rachel F. Buckley et al. JAMA Neurology
- Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma
- (2019) Camilla Steen Jensen et al. EXPERIMENTAL GERONTOLOGY
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
- (2019) Bernard J. Hanseeuw et al. JAMA Neurology
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting
- (2018) Rosebud O. Roberts et al. JAMA Neurology
- Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease
- (2018) Alexandra Litvinchuk et al. NEURON
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis
- (2016) Sulantha Mathotaarachchi et al. Frontiers in Neuroinformatics
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Towards early diagnosis in Alzheimer disease
- (2015) Agneta Nordberg Nature Reviews Neurology
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches
- (2013) Ann D. Cohen et al. NEUROIMAGE
- Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
- (2012) Alix de Calignon et al. NEURON
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Low Prevalence of “Ideal Cardiovascular Health” in a Community-Based Population
- (2011) Claudia Bambs et al. CIRCULATION
- Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture
- (2011) C J Garwood et al. Cell Death & Disease
- Prevalence of Mild Cognitive Impairment by Multiple Classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) Project
- (2010) Mary Ganguli et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
- (2008) Howard Jay Aizenstein et al. ARCHIVES OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search